AMEI's Current Trends in Diagnosis & Treatment

Register      Login

VOLUME 5 , ISSUE 2 ( July-December, 2021 ) > List of Articles

CASE REPORT

Neurofibromatosis II: A Disease of Multicentric Central Nervous System Masses

Arvinder Singh, Manjeet Kaur, Sumanjeet Kaur

Keywords : Magnetic resonance imaging, Neurofibromatosis, Schwannomas

Citation Information : Singh A, Kaur M, Kaur S. Neurofibromatosis II: A Disease of Multicentric Central Nervous System Masses. Curr Trends Diagn Treat 2021; 5 (2):110-113.

DOI: 10.5005/jp-journals-10055-0137

License: CC BY-NC 4.0

Published Online: 08-12-2021

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract

Neurofibromatosis (NF) is an autosomal dominant disorder with two reported types. Neurofibromatosis type I presents with the cutaneous manifestations and involves astrocytes and the neurons. Neurofibromatosis II involves meninges and the Schwann cells in the central nervous system with presentation as bilateral schwannomas, multiple meningiomas, and cord ependymomas. Our present case was presented with bilateral hearing loss and chronic headache. MRI of the brain showed bilateral vestibular schwannomas extending up to bilateral cerebellopontine angle cisterns, mass lesion in relation to the right trigeminal nerve, multiple extra-axial dura-based mass lesions, posterior fossa mixed signal lesion, optic nerve sheath tumors, and two intradural intramedullary cervical cord ependymomas with surrounding cord edema.


HTML PDF Share
  1. Campian J, Gutmann DH. CNS tumors in neurofibromatosis. J Clin Oncol 2017;35(21):2378–2385. DOI: 10.1200/JCO.2016.71.7199.
  2. Hekmatnia A, Ghazavi A, Marashi Shooshtari MJ, et al. Imaging review of neurofibromatosis: helpful aspects for early detection. Iran J Radiol 2011;8(2):63–74. PMID: 23329919.
  3. Borofsky S, Levy LM. Neurofibromatosis: types 1 and 2. Am J Neuroradiol 2013;34(12):2250–2251. DOI: 10.3174/ajnr.A3534.
  4. Rodriguez D, Poussaint TY. Neuroimaging findings in neurofibromatosis type 1 and 2. Neuroimaging Clin N Am 2004;14(2):149–170. DOI: 10.1016/j.nic.2004.03.004.
  5. Gangadhar K, Kumar S, Bhatia L, et al. A complete constellation of nervous system lesions of NF2: imaging evaluation. Case Rep Radiol 2012;2012:353179. DOI: 10.1155/2012/353179.
  6. Swetha P, Omojola MF. Intracranial tumors in neurofibromatosis type 2: a review of magnetic resonance findings. J Radiol Radiat Ther 2014;2(1):1026.
  7. Spilberg G, Marchiori E, Gasparetto EL, et al. Magnetic resonance findings of neurofibromatosis type 2: a case report. Cases J 2009;2(1):6720. DOI: 10.4076/1757-1626-2-6720.
  8. Kollmann P, Mautner VF, Koeppen J, et al. MRI-based volumetric measurements of vestibular schwannomas in patients with neurofibromatosis type 2: comparison of three different software tools. Sci Rep 2020;10(1). DOI: 10.1038/s41598-020-68489-y.
  9. Asthagiri AR, Parry DM, Butman JA, et al. Neurofibromatosis type 2. Lancet 2009;373(9679):1974–1986. DOI: 10.1016/s0140-6736 (09)60259-2.
  10. Rennie ATM, Side L, Kerr RSC, et al. Intramedullary tumors in patients with neurofibromatosis type 2: MRI features associated with a favorable prognosis. Clin Radiol 2008;63(2):193–200. DOI: 10.1016/j.crad.2007.08.003.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.